Biosimilar medicines have the potential to increase medicine access and bring cost savings to consumers, but uptake has been slow for a range of reasons. This article analyses one such reason, namely the potential for competitors' promotional materials to use certain terms with technical meanings, such as "interchangeable" and "substitution", in a misleading way. Against the backdrop of a flawed co-regulatory system for pharmaceutical marketing, the article identifies a need for clear regulatory statements about appropriate uses of such terms in pharmaceutical marketing and promotion.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
pharmaceutical marketing
8
born plastic
4
plastic spoon
4
spoon mouth?
4
mouth? substitution
4
substitution interchangeability
4
interchangeability marketing
4
marketing biosimilars
4
biosimilars biosimilar
4
biosimilar medicines
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!